Literature DB >> 17074042

The slow Wallerian degeneration gene in vivo protects motor axons but not their cell bodies after avulsion and neonatal axotomy.

Robert Adalbert1, Antal Nógrádi, András Szabó, Michael P Coleman.   

Abstract

The slow Wallerian degeneration gene (Wld(S)) delays Wallerian degeneration and axon pathology for several weeks in mice and rats. Interestingly, neuronal cell death is also delayed in some in vivo models, most strikingly in the progressive motoneuronopathy mouse. Here, we tested the hypothesis that Wld(S) has a direct protective effect on motoneurone cell bodies in vivo. Cell death was induced in rat L4 motoneurones by intravertebral avulsion of the corresponding ventral roots. This simultaneously removed most of the motor axon, minimizing the possibility that the protective effect toward axons could rescue cell bodies secondarily. There was no significant difference between the survival of motoneurones in control and Wld(S) rats, suggesting that the Wld(S) gene has no direct protective effect on cell bodies. We also tested for any delay in apoptotic motoneurone death following neonatal nerve injury in Wld(S) rats and found that, unlike Wld(S) mice, Wld(S) rats show no delay in cell death. However, the corresponding distal axons were preserved, confirming that motoneurone cell bodies and motor axons die by different mechanisms. Thus, Wld(S) does not directly prevent death of motoneurone cell bodies. It follows that the protection of neuronal cell bodies observed in several disease and injury models where axons or significant axonal stumps remain is most probably secondary to axonal protection.

Entities:  

Mesh:

Year:  2006        PMID: 17074042     DOI: 10.1111/j.1460-9568.2006.05103.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  16 in total

Review 1.  Wallerian degeneration, wld(s), and nmnat.

Authors:  Michael P Coleman; Marc R Freeman
Journal:  Annu Rev Neurosci       Date:  2010       Impact factor: 12.449

2.  Activation of sirtuin 1 as therapy for the peroxisomal disease adrenoleukodystrophy.

Authors:  L Morató; M Ruiz; J Boada; N Y Calingasan; J Galino; C Guilera; M Jové; A Naudí; I Ferrer; R Pamplona; M Serrano; M Portero-Otín; M F Beal; S Fourcade; A Pujol
Journal:  Cell Death Differ       Date:  2015-03-27       Impact factor: 15.828

Review 3.  Neuronal Cell Death.

Authors:  Michael Fricker; Aviva M Tolkovsky; Vilmante Borutaite; Michael Coleman; Guy C Brown
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

Review 4.  Wallerian degeneration as a therapeutic target in traumatic brain injury.

Authors:  Vassilis E Koliatsos; Athanasios S Alexandris
Journal:  Curr Opin Neurol       Date:  2019-12       Impact factor: 5.710

Review 5.  NAD and axon degeneration: from the Wlds gene to neurochemistry.

Authors:  Jing Wang; Zhigang He
Journal:  Cell Adh Migr       Date:  2009-01-25       Impact factor: 3.405

6.  Maintaining energy homeostasis is an essential component of Wld(S)-mediated axon protection.

Authors:  Hua Shen; Krzysztof L Hyrc; Mark P Goldberg
Journal:  Neurobiol Dis       Date:  2013-07-24       Impact factor: 5.996

Review 7.  Wallerian degeneration: an emerging axon death pathway linking injury and disease.

Authors:  Laura Conforti; Jonathan Gilley; Michael P Coleman
Journal:  Nat Rev Neurosci       Date:  2014-06       Impact factor: 34.870

8.  Retinal ganglion cell survival and axon regeneration in WldS transgenic rats after optic nerve crush and lens injury.

Authors:  Barbara Lorber; Alessia Tassoni; Natalie D Bull; Marilita M Moschos; Keith R Martin
Journal:  BMC Neurosci       Date:  2012-06-06       Impact factor: 3.288

9.  Wld(S) reduces paraquat-induced cytotoxicity via SIRT1 in non-neuronal cells by attenuating the depletion of NAD.

Authors:  Qiujing Yu; Ting Wang; Xuexia Zhou; Jingxia Wu; Xingmiao Chen; Yang Liu; Dongmei Wu; Qiwei Zhai
Journal:  PLoS One       Date:  2011-07-05       Impact factor: 3.240

10.  Differential proteomics analysis of synaptic proteins identifies potential cellular targets and protein mediators of synaptic neuroprotection conferred by the slow Wallerian degeneration (Wlds) gene.

Authors:  Thomas M Wishart; Janet M Paterson; Duncan M Short; Sara Meredith; Kevin A Robertson; Calum Sutherland; Michael A Cousin; Mayank B Dutia; Thomas H Gillingwater
Journal:  Mol Cell Proteomics       Date:  2007-04-29       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.